Authorized purpose: Salix Central is a web-based adjunctive tool for qualified professionals to view, post-process, and analyze cardiac CT DICOM images for physician-identified coronary plaque and stenosis assessment and non-contrast calcium scoring.
Clinical role
Cardiac CT post-processing that supports coronary plaque and stenosis review, non-contrast calcium scoring, vessel measurements, and physician reporting.
Images and patients
CT/CTA · Heart/Cardiovascular
Key limitation
Keep in mind: The software is adjunctive, requires qualified professional review, and does not replace clinical judgment. FDA validation was task-specific and regulatory; it does not establish independent clinical outcomes or performance for every scanner, protocol, or later family version.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Salix Central is a web-based adjunctive tool for qualified professionals to view, post-process, and analyze cardiac CT DICOM images for physician-identified coronary plaque and stenosis assessment and non-contrast calcium scoring.
Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Heart/Cardiovascular Input: Cardiac CT DICOM images: contrast CCTA with physician-identified plaque or stenosis and non-contrast cardiac CT for calcium scoring.
Who uses it?Intended users: Qualified healthcare professionals reviewing adult cardiac CT; the software is adjunctive and does not replace professional judgment.
What does the software produce?Output: Calcium scoring; coronary centerline extraction; vessel labeling; lumen and vessel-wall segmentation; coronary measurements; and a standard coronary report for clinician review.
What is its most important limitation?Key limitation: The software is adjunctive, requires qualified professional review, and does not replace clinical judgment. FDA validation was task-specific and regulatory; it does not establish independent clinical outcomes or performance for every scanner, protocol, or later family version.
Clinical takeaway. Clinical role: Salix Central is a web-based adjunctive tool for qualified professionals to view, post-process, and analyze cardiac CT DICOM images for physician-identified coronary plaque and stenosis assessment and non-contrast calcium scoring.
Evidence takeaway. Evidence from the reviewed source record: K243038 FDA evidence is a six-center regulatory validation of Salix Central cardiac CT post-processing; no independent paper or trial was promoted in this timeboxed review.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Salix Central is a web-based adjunctive tool for qualified professionals to view, post-process, and analyze cardiac CT DICOM images for physician-identified coronary plaque and stenosis assessment and non-contrast calcium scoring.
Calcium scoring; coronary centerline extraction; vessel labeling; lumen and vessel-wall segmentation; coronary measurements; and a standard coronary report for clinician review.
The software is adjunctive, requires qualified professional review, and does not replace clinical judgment. FDA validation was task-specific and regulatory; it does not establish independent clinical outcomes or performance for every scanner, protocol, or later family version.
K243038 FDA evidence is a six-center regulatory validation of Salix Central cardiac CT post-processing; no independent paper or trial was promoted in this timeboxed review.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
K243038 FDA evidence is a six-center regulatory validation of Salix Central cardiac CT post-processing; no independent paper or trial was promoted in this timeboxed review.
DesignRetrospective multi-center regulatory validation of calcium scoring, coronary centerline and labeling, and lumen/vessel-wall segmentation against reference results.
Population363 unique de-identified cardiac CT studies from six centers across three U.S. states; task-specific sets included 302 non-contrast and 116 contrast studies.
Scopeexact submission
Tested versionSalix Central configuration described in K243038
Samplen=363
Sites6
IndependenceSponsor or vendor study
K243038
Manufacturer-submitted FDA evidence; it is not an independent clinical-outcome study. The FDA summary's printed confidence interval for vessel-label F1 is internally malformed and was not promoted as a metric.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The wave22 exact-submission recall query returned no native recall record for K243038. This does not establish absence of family, later-version, or adverse-event information.
Medicare local coverage policy L39881 (Noridian, MAC jurisdictions J-E and J-F) covers AI-enabled coronary plaque analysis from an already completed and interpreted CCTA for stable or acute chest pain with no known coronary disease when the CCTA is intermediate risk or CAD-RADS 1 to 3 and acute coronary syndrome evaluation is negative or inconclusive. It requires FDA cleared or approved software and does not name any product. The related billing article lists CPT 75577 (added effective 2026-01-01, replacing Category III codes 0623T-0626T). This is a regional service-level policy, not a determination that this exact product, version, site or claim is covered or paid. No payment amount was reviewed.
Service-level local coverage policy found (Noridian JE/JF LCD L39881); product-specific coverage and payment not established
Medicare (Noridian Healthcare Solutions MACs, jurisdictions J-E and J-F) · Noridian JE and JF states (California, Nevada, Hawaii, American Samoa, Guam, Northern Mariana Islands, Alaska, Arizona, Idaho, Montana, North Dakota, Oregon, South Dakota, Utah, Washington, Wyoming); other MAC jurisdictions not reviewed · Effective 2026-01-01
Code effective date comes from the billing article revision. LCD requires FDA cleared or approved software but names no product. Does not prove eligibility for a particular product version, patient, indication, site or claim; no payment amount reviewed.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Cardiac CT DICOM images: contrast CCTA with physician-identified plaque or stenosis and non-contrast cardiac CT for calcium scoring.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The exact submission accepts cardiac CT DICOM images through a secured network server and stores images; local PACS/RIS routing, identifiers, report delivery, and retention require acceptance testing.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The FDA packet describes a web-based application using AWS cloud services and a secured network server; it does not establish current hosting region, retention, availability, service-level terms, or the exact deployed cloud configuration.
Scope: Exact FDA submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: Calcium scoring; coronary centerline extraction; vessel labeling; lumen and vessel-wall segmentation; coronary measurements; and a standard coronary report for clinician review.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Calcium scoring; coronary centerline extraction; vessel labeling; lumen and vessel-wall segmentation; coronary measurements; and a standard coronary report for clinician review.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The FDA packet describes a web-based application using AWS cloud services and a secured network server; it does not establish current hosting region, retention, availability, service-level terms, or the exact deployed cloud configuration.
The exact submission accepts cardiac CT DICOM images through a secured network server and stores images; local PACS/RIS routing, identifiers, report delivery, and retention require acceptance testing.
Use requires qualified professional review of coronary measurements, segmentation, calcium scores, and reports; local onboarding should cover CCTA versus non-contrast inputs, editing, report review, and escalation.
The exact FDA submission describes a web-based application using AWS cloud services, secured network-server connectivity, and image storage; confirm the current hosting region, data boundary, retention, and service terms with the vendor.
Artrya's current Salix indication describes a web-based tool for trained professionals that supports cardiac CT plaque, stenosis, and calcium scoring on CT data from any CT scanner as an adjunct to clinical judgment.
product family · checked 2026-09-07
Current family indication; confirm exact K243038 version, scanner compatibility, hosting, licensing, and local interfaces.
Artrya's investor-relations page identifies Salix Central as the U.S. product cleared under K243038; it does not establish every current family feature or contract term for the cleared configuration.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-07Last searched
24Fields reviewed
13Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The stored PubMed and ClinicalTrials.gov candidate arrays were screened and were empty. No paper or trial was promoted; empty stored arrays do not establish that no external literature or trials exist. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, vendor regulatory page, fda device recall, literature index, trial registry, stored candidate metadata, payer policy, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-07 - Exact FDA submission
No public list price or contract unit for the exact K243038 configuration was established in the reviewed official sources.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not publicly available - checked 2026-09-07 - Exact FDA submission
The reviewed exact packet and Artrya family pages do not establish current scoped security controls, certification scope, PHI flow, retention, access control, audit, or incident response for K243038.
Authorized purpose: An extension for syngo.via that assists trained physicians with automated and semi-automated analysis, visualization and reporting of cardiac CT angiography volume datasets for coronary-lesion evaluation, documentation, follow-up and treatment planning.
Authorized purpose: AV Cardiac CT assists radiologists, cardiologists and 3D technologists with viewing, processing and analysis of gated cardiac CT data, including coronary anatomy and cardiac function, to prepare cardiac interventions; physician review and decisions remain required.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.